Covid RNA Analyzed With Tee on OVM: Open (Incl. RSS3) Supercharges DeSci
3.53BUSD
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US05370A1088
CUSIP
N71546100
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
11.03
Dividend Share
-
Dividend Yield
-
Earnings Share
-3
Wall Street Target Price
68.31
EPS Estimate Current Year
-3.97
EPS Estimate Next Year
-4.46
EPS Estimate Current Quarter
-0.8803
EPS Estimate Next Quarter
-0.9155
Most Recent Quarter
-
Revenue TTM
8,927,000
Gross Profit TTM
-327,324,000
EBITDA
-430,345,984
Profit Margin
0.00%
Return On Assets TTM
-22.47%
Return On Equity TTM
-34.19%
Revenue Per Share TTM
0.073
Qtly Revenue Growth YOY
-55.60%
Diluted Eps TTM
-3
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
395.703
Price Book MRQ
2.6594
Enterprise Value Revenue
241
Enterprise Value EBITDA
-5
90.45
1.63%316.89
1.54%188.94
1.42%547.96
1.06%443.01
0.49%511.51
0.45%586.54
0.00%148.56
0.00%246.69
-2.42%77.85
-1.44%Covid RNA Analyzed With Tee on OVM: Open (Incl. RSS3) Supercharges DeSci
GSK buys RNA therapeutics company for up to $50M
Deep Genomics Unveils Groundbreaking AI Foundation Model for RNA Therapeutics